Læknablaðið - 15.02.1990, Side 16

92
LÆKNABLAÐIÐ
67. Young SG, Northey ST, McCarthy BJ. Low plasma
cholesterol levels caused by a short deletion in the
apolipoprotein B gene. Science 1988; 241: 591-3.
68. Bouma ME, Beucler I, Aggerbeck LP, Infante
R, Schmitz J. Hypobetalipoproteinemia with
accumulation of an apoprotein B-like protein in
intestinal cells. J Clin Invest 1986; 78: 398-410.
69. Miller NE. Associations of high-density lipoprotein
subclasses and apolipoproteins with ischemic heart
disease and coronary atherosclerosis. Am Heart J
1987; 113: 589-97.
70. Kuusi T, Kesaniemi YA, Vuoristo M, Miettinen TA,
Koskenvuo M. Inheritance of high density lipoprotein
lipase and hepatic lipase activity. Arteriosclerosis
1987; 4: 421-5.
71. Third JLHC, Montag J, Flynn M, Freidel J,
Laskarzewski P, Glueck CJ. Primary and familial
hypoalphalipoproteinemia. Metabolism 1984; 33: 136-
46.
72. Moll PP, Michels VV, Weidman WH, Kottke A.
Genetic determination of plasma apolipoprotein A1 in
a population-based sample. Am J Hum Genet 1989;
44: 124-39.
73. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin
S, McLeod R, Hewitt J. DNA polymorphisms
in and around the apo-Al-CIII genes and genetic
hyperlipidemias. Am J Hum Genet 1987; 40: 421-30.
74. Breslow JL. Apolipoprotein genetic variation in
human disease. Physiol Rev 1988; 68: 85-132.
75. Gjone E. Familial lecithin: cholesterol acyltransferase
deficiency: A clinical survey. Scand J Clin Lab Invest
1974; 33: suppl. 73-82.
76. Carlson LA. Fish-eye disease: a new familial
condition with massive comeal opacities and
dyslipoproteinaemia. European J Clin Invest 1982;
12: 41-53.
77. Lusis AJ. Genetic factors affecting blood lipoproteins:
the candidate gene approach. J Lipid Res 1988; 29:
397-429.
78. Ordovas JM, Schaefer EJ, Salem D, Ward
RH, Glueck CJ, Vergani C, Wilson PWF et al.
Apolipoprotein A-I gene polymorphism associated
with premature coronary artery disease and familial
hypoalphalipoproteinemia. N Engl J Med 1986; 314
(11): 671-7.
79. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann
G. Human apolipoprotein A-IV polymorphism:
frequency and effect on lipid and lipoprotein levels.
Hum Genet 1988; 79: 368-72.
80. Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-
Will S, Dieplinger H, Utermann G. Frequency and
effect of human apolipoprotein A-IV polymorphism
on lipid and Iipoprotein levels in an Icelandic
population. Bíður birtingar.
81. Becker DM, Becker LC, Pearson TA, Fintel DJ,
Levinde DM, Kwiterovich PO. Risk factors in
siblings of people with premature coronary heart
disease. JACC 1988; 12 (5): 1273-80.
82. Barrett-Connor E, Khaw KT. Family history of heart
attack as an independent predictor of death due to
cardiovascular disease. Circulation 1984; 69 (6):
1065-9.
83. Austin MA, Breslow JL, Hennekens CH, Buring JE,
Willett WC, Krauss RM. Low-density lipoprotein
subclass pattems and risk of myocardial infarction.
JAMA 1988; 260 (13): 1917-21.
84. Rapacz J, Hasler-Rapacz J, Taylor KM, Checovich
WJ, Attie AD. Lipoprotein mutations in pigs are
associated with elevated plasma cholesterol and
atherosclerosis. Science 1986; 234: 1573-7.
85. Apolipoprotein-B and atherogenesis. (Editorial)
Lancet 1988; 21: 1141-2.
86. Goldbourt U, Neufeld HN. Genetic aspects of
arteriosclerosis. Arteriosclerosis 1986; 6: 357-77.
87. Quinn MT, Parthasarathy S, Fong LG, Steinberg
D. Oxidatively modified low density lipoproteins:
A potential role in recmitment and retention of
monocyte/macrophages during atherogenesis. Proc
Natl Acad Sci (USA) 1987; 84: 2995-8.
88. Havel RJ. Lowering cholesterol, 1988. Rationale,
mechanisms and means. J Clin Invest 1988; 81: 1653-
60.